Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
XOMA Royalty Corporation
Acquired Company
Generation Bio
EmeryvilleCambridgeBiotechnologyHealth CareManufacturingGeneticsTherapeuticsDescription
XOMA Royalty Corporation has successfully completed its acquisition of Generation Bio Co. through a tender offer. The acquisition was finalized on February 6, 2026, with Generation Bio becoming a wholly owned subsidiary of XOMA Royalty. Approximately 70% of Generation Bio's outstanding shares were tendered, and all remaining shares were converted into cash and contingent value rights. This marks a significant expansion for XOMA Royalty in the biotechnology sector.
Fundz sees it the moment XOMA Royalty Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Generation Bio?
Generation Bio was acquired by XOMA Royalty Corporation, based in Emeryville. The deal was reported on February 9, 2026. XOMA Royalty Corporation is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty Corporation is privately held and operates in Biotechnology.
When did XOMA Royalty Corporation acquire Generation Bio?
XOMA Royalty Corporation's acquisition of Generation Bio was reported on February 9, 2026. XOMA Royalty Corporation has successfully completed its acquisition of Generation Bio Co. through a tender offer. The acquisition was finalized on February 6, 2026, with Generation Bio becoming a wholly owned subsidiary of XOMA Royalty. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Generation Bio do?
Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. It is privately held, operating in Manufacturing, and is based in Cambridge.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.